Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin.
Adiponectin is a major insulin-sensitizing, multimeric hormone derived from adipose tissue that acts on muscle and liver to regulate whole-body glucose and lipid metabolism. Here, we describe a novel and highly conserved paralog of adiponectin designated as C1q/TNF-related protein (CTRP) 9. Of all the CTRP paralogs, CTRP9 shows the highest degree of amino acid identity to adiponectin in its globular C1q domain. CTRP9 is expressed predominantly in adipose tissue and females expresses higher levels of the transcript than males. Moreover, its expression levels in ob/ob mice changed in an age-dependent manner, with significant up-regulation in younger mice. CTRP9 is a secreted glycoprotein with multiple post-translational modifications in its collagen domain that include hydroxylated prolines and hydroxylated and glycosylated lysines. It is secreted as multimers (predominantly trimers) from transfected cells and circulates in the mouse serum with levels varying according to sex and metabolic state of mice. Furthermore, CTRP9 and adiponectin can be secreted as heterooligomers when cotransfected into mammalian cells, and in vivo, adiponectin/CTRP9 complexes can be reciprocally coimmunoprecipitated from the serum of adiponectin and CTRP9 transgenic mice. Biochemical analysis demonstrates that adiponectin and CTRP9 associate via their globular C1q domain, and this interaction does not require their conserved N-terminal cysteines or their collagen domains. Furthermore, we show that adiponectin and CTRP9 form heterotrimers. In cultured myotubes, CTRP9 specifically activates AMPK, Akt, and p44/42 MAPK signaling pathways. Adenovirus-mediated overexpression of CTRP9 in obese (ob/ob) mice significantly lowered serum glucose levels. Collectively, these results suggest that CTRP9 is a novel adipokine, and further study of CTRP9 will yield novel mechanistic insights into its physiological and metabolic function.
Wong
G William
GW
Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Krawczyk
Sarah A
SA
Kitidis-Mitrokostas
Claire
C
Ge
Guangtao
G
Spooner
Eric
E
Hug
Christopher
C
Gimeno
Ruth
R
Lodish
Harvey F
HF
D052242:Adiponectin / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D001786:Blood Glucose; D003001:Cloning, Molecular; D005786:Gene Expression Regulation / Q000502:physiology; D006023:Glycoproteins / Q000235:genetics / Q000378:metabolism*; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice
D052242:Adiponectin; C499919:Adipoq protein, mouse; D001786:Blood Glucose; C534692:CTRP9 protein, mouse; D006023:Glycoproteins; D008565:Membrane Proteins
Nat Med. 2005 Oct;11(10):1096-103
16155579
Nature. 2001 Dec 13;414(6865):799-806
11742412
Gene. 1991 Dec 15;108(2):193-9
1660837
Hum Mol Genet. 2002 Oct 1;11(21):2607-14
12354786
Endocrinology. 2004 Jan;145(1):367-83
14576179
J Biol Chem. 2002 Jul 19;277(29):25863-6
12032136
J Biol Chem. 1992 Jan 5;267(1):473-8
1730610
Nat Med. 2002 Jul;8(7):731-7
12068289
Diabetes. 2005 May;54(5):1304-13
15855314
Diabetes. 2003 Feb;52(2):268-76
12540596
Diabetes. 2004 May;53(5):1369-74
15111508
J Biol Chem. 2005 May 6;280(18):18073-80
15760892
Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83
10092513
Trends Endocrinol Metab. 2002 Mar;13(2):84-9
11854024
Diabetes. 2001 Sep;50(9):2094-9
11522676
Circulation. 2002 Nov 26;106(22):2767-70
12451000
Nature. 2003 Jun 12;423(6941):762-9
12802337
EMBO J. 1989 Jul;8(7):1939-46
2551668
J Biol Chem. 2003 Mar 14;278(11):9073-85
12496257
Proteomics. 2006 Jul;6(13):3862-70
16767790
J Neurosci. 2000 Sep 1;20(17):6333-9
10964938
J Biol Chem. 2006 Jun 16;281(24):16391-400
16621799
Mol Endocrinol. 2006 Jul;20(7):1673-87
16497731
Nat Neurosci. 2005 Nov;8(11):1534-41
16234806
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10308-13
15210937
Immunopharmacology. 2000 Aug;49(1-2):159-70
10904115
J Biol Chem. 2006 Dec 15;281(50):38117-21
17082192
J Biol Chem. 2002 Sep 20;277(38):34658-61
12151381
J Biol Chem. 2003 Jan 24;278(4):2461-8
12431986
Diabetes. 2005 Sep;54(9):2712-9
16123361
J Biol Chem. 1991 May 5;266(13):8626-33
2022673
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10302-7
15231994
J Biol Chem. 2003 Oct 10;278(41):40352-63
12878598
Curr Drug Targets Immune Endocr Metabol Disord. 2003 Dec;3(4):243-54
14683455
FEBS Lett. 2007 Mar 6;581(5):809-14
17292892
Diabetes. 2004 Jun;53(6):1621-9
15161771
J Biol Chem. 1995 Nov 10;270(45):26746-9
7592907
J Biol Chem. 2002 May 31;277(22):19521-9
11912203
Diabetes. 2002 Feb;51(2):536-40
11812766
J Biol Chem. 2004 Mar 26;279(13):12152-62
14699128
Biopolymers. 2001 Apr 15;58(5):459-64
11241217
Anal Biochem. 2000 Apr 10;280(1):20-8
10805516
J Clin Endocrinol Metab. 2001 May;86(5):1930-5
11344187
J Biol Chem. 2003 Dec 12;278(50):50810-7
14522956
Mol Cell Biol. 2006 Dec;26(24):9327-37
17030622
Diabetes. 2006 Jul;55(7):1954-60
16804063
J Biol Chem. 2002 Aug 16;277(33):29359-62
12087086
Mol Cell Biol. 1993 Mar;13(3):1516-21
8441393
Diabetes. 2002 Jul;51(7):2325-8
12086969
Curr Biol. 1998 Mar 12;8(6):335-8
9512423
JAMA. 2003 Apr 9;289(14):1799-804
12684358
Nat Med. 2001 Aug;7(8):947-53
11479628
Genome Res. 2003 Oct;13(10):2265-70
12975309
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1595-9
10845877
J Clin Invest. 2001 Dec;108(12):1875-81
11748271
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2005-10
11172066
Endocrinology. 2005 Feb;146(2):790-6
15528304
Nat Med. 2002 Nov;8(11):1288-95
12368907
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16309-13
12456889
J Clin Invest. 2003 Jul;112(1):91-100
12840063
Blood. 1998 Nov 15;92(10):3829-40
9808576
Nat Med. 2001 Aug;7(8):941-6
11479627
Biochem Biophys Res Commun. 1996 Apr 16;221(2):286-9
8619847
Diabetologia. 2005 Jun;48(6):1084-7
15902402
Nat Med. 2004 Dec;10(12):1384-9
15558058
J Biol Chem. 1996 May 3;271(18):10697-703
8631877